Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
UQ researchers contributed to the characterisation of ziconotide (an approved conotoxin-derived analgesic), one of Australia's most significant contributions to peptide therapeutics
Warrell RP Jr, Lee BJ, Kempin SJ, et al
Formulated at a total peptide mass of 12mg per vial, this blend delivers a research-grade concentration designed for serious in vitro and in vivo experimental protocols
L., McGowan, B., Mosenzon, O., Pedersen, S
It is not intended for: Human or animal consumption Injection or self-administration Treatment, cure, or mitigation of any disease Clinical or therapeutic use Cosmetic or wellness use Use must comply with all applicable institutional, provincial, and federal regulations governing research chemicals and biologically active peptides
US$ 22.14
US$ 25.90
US$ 22.08
